Aromatase and 5α-Reductase Inhibition during an Exogenous Testosterone Clamp Unveils Selective Sex Steroid Modulation of Somatostatin and Growth Hormone Secretagogue Actions in Healthy Older Men
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Background: How endogenous testosterone (Te), 5α-dihydrotestosterone (DHT), and estradiol (E2) regulate pulsatile GH secretion is not understood. Hypothesis: Conversion of Te to androgenic (Te→DHT) or estrogenic (Te→E2) products directs GH secretion. Subjects and Location: Healthy older men (N = 42, ages 50–79 yr) participated at an academic medical center. Methods: We inhibited 5α-reduction with dutasteride and aromatization with anastrozole during a pharmacological Te clamp and infused somatostatin (SS), GHRH, GH-releasing peptide-2 (GHRP-2), and l-arginine/GHRH/GHRP-2 (triple stimulus) to modulate GH secretion. Endpoints: Deconvolution-estimated basal and pulsatile GH secretion was assessed. Results: Administration of Te/placebo elevated Te by 2.8-fold, DHT by 2.6-fold, and E2 concentrations by 1.9-fold above placebo/placebo. Te/dutasteride and Te/anastrozole reduced stimulated DHT and E2 by 89 and 86%, respectively. Stepwise forward-selection regression analysis revealed that 1) Te positively determines mean (P = 0.017) and peak (P < 0.001) GH concentrations, basal GH secretion (P = 0.015), and pulsatile GH secretion stimulated by GHRP-2 (P < 0.001); 2) Te and E2 jointly predict GH responses to the triple stimulus (positively for Te, P = 0.006, and negatively for E2, P = 0.031); and 3) DHT correlates positively with pulsatile GH secretion during SS infusion (P = 0.011). These effects persisted when abdominal visceral fat was included in the regression. Conclusion: The present outcomes suggest a tetrapartite model of GH regulation in men, in which systemic concentrations of Te, DHT, and E2 along with abdominal visceral fat determine the selective actions of GH secretagogues and SS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Giustina, A., & Veldhuis, J. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0353 · Cited by 1,253
Self-citationAge-related change in the twenty-four-hour spontaneous secretion of growth hormone
FINKELSTEIN, J. W., ROFFWARG, H. P., BOYAR, R. M., KREAM, J., & HELLMAN, L. (1972) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-35-5-665 · Cited by 640
MAURAS, N., BLIZZARD, R. M., LINK, K., JOHNSON, M. L., ROGOL, A. D., & VELDHUIS, J. D. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-3-596 · Cited by 300
Self-citationLund, T. D., Hinds, L. R., & Handa, R. J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3777-05.2006 · Cited by 236
Shuto, Y., Shibasaki, T., Otagiri, A., Kuriyama, H., Ohata, H., Tamura, H., Kamegai, J., Sugihara, H., Oikawa, S., & Wakabayashi, I. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213300 · Cited by 220 · cited 1×
“transgenic silencing of the murine pituitary GHRH or hypothalamic ghrelin receptor reduce GH secretion, IGF-I concentrations, and/or stature (7, 11, 12).”
Weissberger, A. J., & Ho, K. K. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.6.8501143 · Cited by 185
Metzger, D. L., & Kerrigan, J. R. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.2.8045971 · Cited by 152 · cited 1×
“Previous studies indicate that nonsteroidal estrogen receptor (ER) and androgen receptor (AR) blockers decrease and increase GH secretion, respectively (18, 19, 21).”
Mauras, N., Rogol, A. D., & Veldhuis, J. D. (1990) · Pediatric Research · doi:10.1203/00006450-199012000-00018 · Cited by 127
Self-citationRoelfsema, F., Biermasz, N. R., Veldman, R. G., Veldhuis, J. D., Frölich, M., Stokvis-Brantsma, W. H., & Wit, J.-M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7536 · Cited by 106
Self-citationUnequal impact of short-term testosterone repletion on the somatotropic axis of young and older men.
Gentili, A., Mulligan, T., Godschalk, M., Clore, J., Patrie, J., Iranmanesh, A., & Veldhuis, J. D. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8222 · Cited by 98 · cited 4×
“Healthy older men were studied, because high Te concentrations augment 24-h pulsatile GH secretion in aging but not young individuals (20).”
InfluentialSelf-citation
Research works printed but not linked: 45
- Veldhuis, 2006, Somatotropic and gonadotropic axes linkages in infancy, childhood, and the puberty-adult transition., Endocr Rev, 27, 101, 10.1210/er.2005-0006 · DOI · Paper page
- Kojima, 2000, Ghrelin is a growth-hormone-releasing acylated peptide from stomach., Nature, 402, 656, 10.1038/45230 · DOI · Paper page
- Arvat, 2001, Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone., J Clin Endocrinol Metab, 86, 1169
- Bowers, 1999, GH releasing peptides (GHRPs), Kostyo J, Goodman H, eds. Handbook of physiology. New York: Oxford University Press;, 267
- Korbonits, 2001, The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors., J Clin Endocrinol Metab, 86, 881
- Pantel, 2006, Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature., J Clin Invest, 116, 760, 10.1172/JCI25303 · DOI · Paper page
- Iranmanesh, 1998, Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men., Eur J Endocrinol, 139, 59, 10.1530/eje.0.1390059 · DOI · Paper page
- Veldhuis, 1995, Differential impact of age, sex-steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay., J Clin Endocrinol Metab, 80, 3209
- Muniyappa, 2007, Long-term testosterone supplementation augments overnight growth hormone secretion in healthy older men, Am J Physiol Endocrinol Metab, 293, E769, 10.1152/ajpendo.00709.2006 · DOI
- Veldhuis, 2006, Estradiol potentiates ghrelin-stimulated pulsatile GH secretion in postmenopausal women., J Clin Endocrinol Metab, 91, 3559, 10.1210/jc.2006-0948 · DOI
- Veldhuis, 2004, Estradiol supplementation in postmenopausal women doubles rebound-like release of growth hormone (GH) triggered by sequential infusion and withdrawal of somatostatin: evidence that estrogen facilitates endogenous GH-releasing hormone drive., J Clin Endocrinol Metab, 89, 121, 10.1210/jc.2003-031291 · DOI · Paper page
- Bray, 2001, Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin’s dose-dependent inhibition of fasting growth hormone secretion., J Clin Endocrinol Metab, 86, 3143
- Rigamonti, 2006, Testosterone inhibition of growth hormone release stimulated by a growth hormone secretagogue: studies in the rat and dog., Neuroendocrinology, 84, 115, 10.1159/000096998 · DOI
- Veldhuis, 2005, Testosterone supplementation in healthy older men drives GH and IGF-I secretion without potentiating peptidyl secretagogue efficacy., Eur J Endocrinol, 153, 577, 10.1530/eje.1.02001 · DOI · Paper page
- Loche, 1997, The growth hormone response to hexarelin in children: reproducibility and effect of sex steroids., J Clin Endocrinol Metab, 82, 861
- Fryburg, 1997, Short-term modulation of the androgen milieu alters pulsatile but not exercise or GHRH-stimulated GH secretion in healthy men., J Clin Endocrinol Metab, 82, 3710
- Keenan, 1993, Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty., J Clin Endocrinol Metab, 76, 996
- Paulo, 2008, Gonadal status and body-mass index jointly determine GHRH/GHRP synergy in healthy men., J Clin Endocrinol Metab, 93, 944, 10.1210/jc.2007-1388 · DOI
- Kamegai, 2001, Estrogen receptor (ER)α, but not ERβ, gene is expressed in growth hormone-releasing hormone neurons of the male rat hypothalamus., Endocrinology, 142, 538, 10.1210/endo.142.2.7933 · DOI
- Yan, 2004, Functional modification of pituitary somatotropes in the aromatase knockout mouse and the effect of estrogen replacement., Endocrinology, 145, 604, 10.1210/en.2003-0646 · DOI
- Kimura, 1998, Chronic treatment with estrogen up-regulates expression of sst2 messenger ribonucleic acid (mRNA) but down-regulates expression of sst5 mRNA in rat pituitaries., Endocrinology, 139, 1573, 10.1210/endo.139.4.5952 · DOI · Paper page
- Sanford, 2008, Anastrozole: a review of its use in postmenopausal women with early-stage breast cancer., Drugs, 68, 1319, 10.2165/00003495-200868090-00007 · DOI
- Keam, 2008, Dutasteride: a review of its use in the management of prostate disorders., Drugs, 68, 463, 10.2165/00003495-200868040-00008 · DOI
- Veldhuis, 2005, Distinctive inhibitory mechanisms of age and relative visceral adiposity on GH secretion in pre- and postmenopausal women studied under a hypogonadal clamp., J Clin Endocrinol Metab, 90, 6006, 10.1210/jc.2005-0854 · DOI
- Paulo, 2008, Estrogen elevates the peak overnight production rate of acylated ghrelin., J Clin Endocrinol Metab, 93, 4440, 10.1210/jc.2008-0783 · DOI
- Cosma, 2008, Pituitary and/or peripheral estrogen-receptor α (ERα) regulates FSH secretion whereas central pathways direct GH and prolactin secretion in postmenopausal women., J Clin Endocrinol Metab, 93, 951, 10.1210/jc.2007-1322 · DOI
- Keenan, 2003, Physiological control of pituitary hormone secretory-burst mass, frequency and waveform: a statistical formulation and analysis, Am J Physiol, 285, R664
- Faria, 1989, Half-time of endogenous growth hormone (GH) disappearance in normal man after stimulation of GH secretion by GH-releasing hormone and suppression with somatostatin., J Clin Endocrinol Metab, 68, 535, 10.1210/jcem-68-3-535 · DOI · Paper page
- Petersenn, 2001, Genomic structure and transcriptional regulation of the human growth hormone secretagogue receptor., Endocrinology, 142, 2649, 10.1210/endo.142.6.8184 · DOI · Paper page
- Djordjijevic, 1998, Effect of 17β-estradiol on somatostatin receptor expression and inhibitory effects on growth hormone and prolactin release in rat pituitary cell cultures., Endocrinology, 139, 2272, 10.1210/endo.139.5.5990 · DOI
- Childs, 2005, Bipotential effects of estrogen on growth hormone synthesis and storage in vitro., Endocrinology, 146, 1780, 10.1210/en.2004-1111 · DOI
- Scanlan, 2003, Somatostatin-14 neurons in the ovine hypothalamus: colocalization with estrogen receptor α and somatostatin-28(1–12) immunoreactivity, and activation in response to estradiol., Biol Reprod, 69, 1318, 10.1095/biolreprod.103.017848 · DOI
- Bouyer, 2006, Sexually dimorphic distribution of SST2A receptors on GHRH neurons in mice., Endocrinology, 147, 2670, 10.1210/en.2005-1462 · DOI
- Clegg, 2007, Estradiol-dependent decrease in the orexigenic potency of ghrelin in female rats., Diabetes, 56, 1051, 10.2337/db06-0015 · DOI · Paper page
- De Marinis, 2000, Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer., Clin Endocrinol (Oxf), 52, 681, 10.1046/j.1365-2265.2000.00991.x · DOI
- Corsello, 1998, Effect of acute and chronic administration of tamoxifen on GH response to GHRH and on IGF-I serum levels in women with breast cancer., Eur J Endocrinol, 139, 309, 10.1530/eje.0.1390309 · DOI
- Veldhuis, 2007, Peripheral estrogen receptor-α selectively modulates the waveform of GH secretory bursts in healthy women, Am J Physiol Regul Integr Comp Physiol, 293, R1514, 10.1152/ajpregu.00438.2007 · DOI
- Cho, 2002, Structure and dynamics of the fusion pores in live GH-secreting cells revealed using atomic force microscopy., Endocrinology, 143, 1144, 10.1210/endo.143.3.8773 · DOI
- Lam, 1996, Gene expression of the receptor for growth-hormone-releasing hormone is physiologically regulated by glucocorticoids and estrogen., Neuroendocrinology, 63, 475, 10.1159/000127075 · DOI · Paper page
- Tena-Sempere, 2001, Neonatal imprinting and regulation of estrogen receptor α and β mRNA expression by estrogen in the pituitary and hypothalamus of the male rat., Neuroendocrinology, 73, 12, 10.1159/000054616 · DOI · Paper page
- Aguilar, 1992, 5α-Androstanediol stimulates the pituitary growth hormone responsiveness to growth hormone releasing hormone more effectively than testosterone or dihydrotestosterone in rats., Acta Endocrinol (Copenh), 126, 162, 10.1530/acta.0.1260162 · doi:10.1530/acta.0.1260162
- Orrego, 2004, Physiological testosterone replenishment in healthy elderly men does not normalize pituitary growth hormone output: evidence against the connection between senile hypogonadism and somatopause., J Clin Endocrinol Metab, 89, 3255, 10.1210/jc.2003-031530 · DOI
- Bondanelli, 2003, Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone-releasing hormone., Neuroendocrinology, 77, 380, 10.1159/000071310 · DOI · Paper page
- Liu, 1987, Chronic sex steroid exposure increases mean plasma growth hormone concentration and pulse amplitude in men with isolated hypogonadotropic hypogonadism., J Clin Endocrinol Metab, 64, 651, 10.1210/jcem-64-4-651 · DOI · Paper page
- Veldhuis, 2004, Short-term testosterone supplementation relieves growth hormone autonegative feedback in men., J Clin Endocrinol Metab, 89, 1285, 10.1210/jc.2003-031017 · DOI
Cited by
Estrogens and androgens in skeletal physiology and pathophysiology
Almeida, M., Laurent, M. R., Dubois, V., Claessens, F., O'Brien, C. A., Bouillon, R., Vanderschueren, D., & Manolagas, S. C. (2017) · Physiological Reviews · doi:10.1152/physrev.00033.2015 · Cited by 860
Aromatase inhibitors in men: effects and therapeutic options
de Ronde, W., & de Jong, F. H. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-93 · Cited by 155
Sex steroids and the GH axis: implications for the management of hypopituitarism
Birzniece, V., & Ho, K. K. Y. (2017) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2017.03.003 · Cited by 65
Veldhuis, J. D., Roelfsema, F., Keenan, D. M., & Pincus, S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1669 · Cited by 53
Birzniece, V., Sata, A., Sutanto, S., & Ho, K. K. Y. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1477 · Cited by 22
“The role of local estrogen is supported by the observation that treatment with aromatase inhibitor attenuates testosterone-induced increase in GH levels (5), and that nonaromatizable androgens do not stimulate GH secretion in peripubertal boys (4).”
Background
Metadata
- Authors
- Veldhuis, J. D., Mielke, K. L., Cosma, M., Soares-Welch, C., Paulo, R., Miles, J. M., & Bowers, C. Y.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2009-03-01
- Volume
- 94
- Issue
- 3
- Pages
- 973-981
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2143985871
- Cited by
- 42
- References
- 17
- FWCI
- 2.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Aromatase and 5α-Reductase Inhibition during an Exogenous Testosterone Clamp Unveils Selective Sex Steroid Modulation of Somatostatin and Growth Hormone Secretagogue Actions in Healthy Older Men. https://app.cochat.ai/papers/10.1210/jc.2008-2108
- The paper
- Veldhuis, J. D., Mielke, K. L., Cosma, M., Soares-Welch, C., Paulo, R., Miles, J. M., & Bowers, C. Y. (2009). Aromatase and 5α-Reductase Inhibition during an Exogenous Testosterone Clamp Unveils Selective Sex Steroid Modulation of Somatostatin and Growth Hormone Secretagogue Actions in Healthy Older Men. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2008-2108
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.